Previous studies have suggested that biomarkers such as the fibrinogen-to-albumin ratio, urinary protein, urinary albumin, glycated hemoglobin, neutrophil gelatinase-associated lipocalin, kidney injury molecule-1, liver-type fatty acid-binding protein [25], and other indicators can be used to predict AKI mortality accurately. This evidence concerns the gene ALB and acute kidney injury.